ION 2 (IACB) Shareholders Approve Innovid Deal
by Marlena Haddad on 2021-11-30 at 6:27am

ION Acquisition Corp 2 Ltd. (NYSE:IACB) secured shareholder approval of its combination with ad delivery platform Innovid in a special meeting yesterday.

The combination was approved by 97.4% of participating shares, but it also saw 19,585,174 shares redeemed, removing about 77.4% of the value of its trust, estimated at $253 million heading into the vote.

The deal will still bring $251 million in proceeds to Innovid after redemptions and expenses, which narrowly clears the bar of its $250 million minimum cash condition. But, the transaction was likely not at risk of missing this threshold as ION 2 added $50 million to the PIPE in late October to support the transaction and its sponsor has said it would purchase additional shares if need be towards close.

ION 2 now expects to close the deal later today and the combined company’s ordinary shares and warrants are set to begin trading on the NYSE beginning on Wednesday, December 1 under the ticker symbols “CTV” and “CTV.WS” respectively.

ION 2 initially announced its $1.1 billion deal with Innovid in June. New York-based Innovid is an omnichannel advertising and analytics platform placing video marketing on streaming and social media services.

Innovid is set to be the second ad company that started up in Israel that the ION team has taken to public markets this year having announced a deal with Taboola (NASDAQ:TBLA) in January. TBLA closed yesterday at $8.15.


ADVISORS

  • Evercore LLC acted as sole financial and capital markets advisor to Innovid and also acted as a placement agent on the PIPE.
  • Latham & Watkins LLP and FWMK Law Offices acted as legal counsel to Innovid.
  • Morgan Stanley acted as sole financial advisor to ION and also acted as lead placement agent to ION on the PIPE.
  • White & Case LLP and Goldfarb Seligman & Co. acted as legal counsel to ION.
  • Debevoise & Plimpton LLP acted as legal counsel to the placement agents.
  • Kost Forer, Gabbay & Kasierer, a member of Ernst & Young Global Limited, is acting as independent auditor.
Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved